MARGARET MCLAIN: Open Payments
NPI 1578601282 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 29 payments from 5 companies in 2025. Trend: 2023 $1,179 · 2024 $2,462 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 6 | $254 |
| ABBVIE INC. | 11 | $182 |
| MERZ NORTH AMERICA, INC. | 10 | $162 |
| Galderma Laboratories, L.P. | 1 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: DAXXIFY, Xeomin, BOTOX, Kyleena.
Industry payments across CA — which companies pay providers there.
